BENEVICH ERIC (CIK 1643653) reported 21 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-17). Recent activity: Buy NBIX (2,005 shares), Sell NBIX (1,082 shares), Buy NBIX (1,961 shares), Sell NBIX (1,058 shares), Buy NBIX (2,083 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 2,005 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 1,082 | $133,194 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 1,961 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 1,058 | $131,319 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 2,083 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 1,124 | $139,511 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 16,613 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 8,963 | $1.1M |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 2,294 | $0 |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 1,292 | $175,790 |
| 2026-01-16 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 12,830 | $461,752 |
| 2025-12-02 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 5,970 | $214,860 |
| 2025-12-02 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 5,970 | $905,888 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 2,083 | $0 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 1,098 | $128,181 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 1,961 | $0 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 1,056 | $123,246 |
| 2025-02-12 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 1,860 | $0 |
| 2025-02-12 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 980 | $115,944 |
| 2025-02-04 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 2,294 | $0 |
| 2025-02-04 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 1,207 | $184,599 |
Source: SEC Form 4 filings · as of 2026-02-17